Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Whole Body Non-Contrast MRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
Whole exome sequencing
United Therapeutics Europe Ltd
Healthy Adults
1 trial -
Whole peanuts without skins, Peanut butter, or no peanuts (control)
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
Wild blueberry containing foods
United Therapeutics Europe Ltd
Healthy
1 trial -
Window of Implantation
Inhibitor Therapeutics
IVF
1 trial -
Wobenzym PS
Atrium Therapeutics
Sub-clinical Inflammation
1 trial -
Xuebi formula
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Peripheral Neuropathy
1 trial -
Zinc gluconate
Grace Therapeutics
HIV
1 trial -
active tDCS and cognitive training intervention
United Therapeutics Europe Ltd
Brain Concussion
2 trials -
alteplase or tenecteplase
United Therapeutics Europe Ltd
CVA (Cerebrovascular Accident)
1 trial -
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect Increased
1 trial -
anti-thymocyte globulin
United Therapeutics Europe Ltd
Leukemia
1 trial -
bismuth-containing quadral therapy based on antibiotic susceptibility
Shandong University
Helicobacter Pylori
1 trial -
blood draw from three different vessels
Sionna Therapeutics
Accidental Hypothermia
1 trial -
blood sampling
Marker Therapeutics
Screening for Colon Cancer
1 trial -
blood sampling
Marker Therapeutics
Colorectal Cancer Screening
1 trial -
bpMRI
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
brachytherapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
carotid-femoral pulse-wave velocity
Structure Therapeutics
Covid19
1 trial -
chemotherapy
United Therapeutics Europe Ltd
Malignant Mesothelioma
1 trial -
chemotherapy plus TCM 1&ICIs plusTCM2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
conventional radiotherapy 74 Gy delivered in 37 fractions
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
etomidate anesthesia
Xiyuan Hospital of China Academy of Chinese Medical Sciences
General Anesthesia
1 trial -
extended release niacin
United Therapeutics Europe Ltd
HIV Infections
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources